NDC 82922-019 - Truemed Group LLC
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 82922-019
- Package NDCs from labels
- 82922-019-01
- Manufacturer
- Truemed Group LLC
- Effective date
- 2022-08-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| IRBESARTAN-HYDROCHLOROTHIAZIDE - Truemed Group LLC | Truemed Group LLC | 2022-08-10 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Olmesartan medoxomil and hydrochlorothiazide | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | Camber Pharmaceuticals, Inc. | d421f352-9500-4d3e-8bc3-0cdcc2050514 | 2025-08-26 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | PD-Rx Pharmaceuticals, Inc. | 67bedecc-f758-4bc6-82c5-7d428cbbbd9b | 2025-08-22 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | d7d0867a-748e-4960-851f-ad764e07f774 | 2025-08-20 | Warnings, Adverse reactions | 0J48LPH2TH |
| telmisartan and hydrochlorothiazide | TELMISARTAN AND HYDROCHLOROTHIAZIDE | Lifestar Pharma LLC | 0c1bd0f4-034e-486c-ae46-2855c8c9ebda | 2025-08-20 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | PD-Rx Pharmaceuticals, Inc. | 473d90ed-e262-4ec6-975b-494d89f1ad70 | 2025-08-18 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Oxford Pharmaceuticals, LLC | afbb9a0e-c22f-4133-8015-b4b2ab4d32e6 | 2025-08-18 | Warnings, Adverse reactions | 0J48LPH2TH |
| Irbesartan | IRBESARTAN | Unichem Pharmaceuticals (USA), Inc. | fdf196d5-e933-49de-9c4c-bde50149c7d4 | 2025-08-13 | Boxed warning, Warnings, Adverse reactions | J0E2756Z7N |
| Irbesartan | IRBESARTAN | A-S Medication Solutions | 70a25c6d-23ce-488c-9ef8-62b3b99e5052 | 2025-08-08 | Boxed warning, Warnings, Adverse reactions | J0E2756Z7N |
| Irbesartan | IRBESARTAN | A-S Medication Solutions | 6babdb48-8384-49ce-a759-d380d79a4010 | 2025-08-08 | Boxed warning, Warnings, Adverse reactions | J0E2756Z7N |
| losartan potassium and hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | f9cfb39e-4367-40a0-86ee-138645aace56 | 2025-08-07 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| losartan potassium and hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 3c873a8c-b21e-448e-87f3-333419739cdd | 2025-08-07 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Aurobindo Pharma Limited | dc177d6c-c754-4379-8c2f-1cf6f52f950a | 2025-08-06 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Olmesartan medoxomil Amlodipine and Hydrochlorothiazide | OLMESARTAN MEDOXOMIL AMLODIPINE AND HYDROCHLOROTHIAZIDE | Macleods Pharmaceuticals Limited | 52c013e1-8c31-4bed-9241-e7845873ebe8 | 2025-08-04 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Preferred Pharmaceuticals Inc. | 46cf633d-70a5-4d3b-b349-ad74c23ddace | 2025-08-04 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Preferred Pharmaceuticals Inc. | 24ee299f-4466-45d4-9013-17791e1998bb | 2025-08-04 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| VALSARTAN AND HYDROCHLOROTHIAZIDE | VALSARTAN AND HYDROCHLOROTHIAZIDE | Solco Healthcare US, LLC | f8b0a8ab-4549-4553-a127-bf2c0291a4b1 | 2025-07-31 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals, Inc. | 3b3c92b1-bec3-2768-e063-6394a90a9af8 | 2025-07-31 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | Solco Healthcare LLC | 96922ddc-e87f-4670-b22e-0ffd0d8f66e1 | 2025-07-25 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Spironolactone and Hydrochlorothiazide | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | Mylan Institutional Inc. | f2a4fbc0-650b-440d-9555-c1720fe0fe35 | 2025-07-22 | Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Macleods Pharmaceuticals Limited | a04b5622-2c49-4d61-92b1-5dc523af7a24 | 2025-07-21 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.